BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/30/2018 7:38:56 AM | Browse: 1063 | Download: 1406
 |
Received |
|
2018-05-25 00:52 |
 |
Peer-Review Started |
|
2018-05-25 02:04 |
 |
To Make the First Decision |
|
2018-07-04 01:16 |
 |
Return for Revision |
|
2018-07-06 07:20 |
 |
Revised |
|
2018-08-18 11:12 |
 |
Second Decision |
|
2018-08-22 02:08 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2018-08-24 09:31 |
 |
Articles in Press |
|
2018-08-24 09:31 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2018-09-26 08:34 |
 |
Publish the Manuscript Online |
|
2018-09-30 07:38 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Critical Care Medicine |
Manuscript Type |
Review |
Article Title |
New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma
|
Manuscript Source |
Invited Manuscript |
All Author List |
Leonardo Lorente |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Leonardo Lorente, MD, PhD, Attending Doctor, Medical Assistant, Intensive Care Unit, Hospital Universitario de Canarias, Ofra, s/n, 38320, Santa Cruz de Tenerife, Spain. lorentemartin@msn.com |
Key Words |
Liver transplantation; Hepatocellular carcinoma; Biomarkers; Outcome; Survival; Recurrence; Genomic |
Core Tip |
The outcome of liver transplantation (LT) for hepatocellular carcinoma (HCC) patients are generally predicted using various macromorphological factors and serum alpha-fetoprotein levels prior to LT. However, other biomarkers have recently been reported to be associated with the prognosis of HCC patients undergoing LT. Furthermore, some of these biomarkers are also interesting because their potential modulation could help to create new research lines for improving the outcomes of those patients. This review summarizes clinical data on those new biomarkers. |
Publish Date |
2018-09-30 07:38 |
Citation |
Lorente L. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma. World J Gastroenterol 2018; 24(37): 4230-4242 |
URL |
http://www.wjgnet.com/1007-9327/full/v24/i37/4230.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v24.i37.4230 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345